Exploring the link between cystic fibrosis and periodontal diseases
Prevalence of Periodontal Disease in Adult Patients Suffering From Cystic Fibrosis in the University Hospital of Reims: a Pilot Study
NA · CHU de Reims · NCT06133335
This study is trying to see how common gum diseases are in adults with cystic fibrosis and how these issues relate to their overall health and treatments.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | CHU de Reims (other) |
| Locations | 1 site (Reims) |
| Trial ID | NCT06133335 on ClinicalTrials.gov |
What this trial studies
This study aims to determine the prevalence of periodontal diseases, such as periodontitis and gingivitis, in adults with cystic fibrosis (CF) at the CRCM of the CHU of Reims. It will involve clinical examinations using specific periodontal probes to assess various clinical indices related to oral health. Additionally, the study will investigate associations between periodontal disease and factors like CFTR genotype, ventilatory capacity, and treatments administered. The research also aims to evaluate the prevalence of carious lesions and the impact of CF on oral health-related quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with cystic fibrosis who are consulting at the Resource and Competence Center for Cystic Fibrosis of the C.H.U. from Reims.
Not a fit: Patients with medical histories that could compromise the protocol, such as psychiatric disorders or cancer, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved oral health management strategies for cystic fibrosis patients, enhancing their overall quality of life.
How similar studies have performed: While the specific focus on periodontal diseases in cystic fibrosis patients is less explored, related studies have shown associations between oral health and systemic conditions, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
inclusion criteria : * Adult patients affected by cystic fibrosis consulting the Resource and Competence Center for Cystic Fibrosis of the C.H.U. from Reims * Patient who signed the consent * Patient affiliated to the French social security system exclusion criteria : * A medical history that could compromise the protocol (psychiatric, medical disorders) * Cancer * Pregnancy * Patients protected by law, minors, adults under guardianship and curatorship, people hospitalized without their consent and not protected by law, or people deprived of their liberty
Where this trial is running
Reims
- Damien JOLLY — Reims, France (RECRUITING)
Study contacts
- Study coordinator: Anne QUINQUENEL
- Email: aquinquenel@chu-reims.fr
- Phone: 03 26 78 74 76
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cystic Fibrosis, Periodontitis, Gingivitis, Cystic fibrosis, gingivitis